CD24 is a Potential Biomarker for Prognosis in Human Breast Carcinoma.

Jing X, Cui X, Liang H, Hao C, Yang Z, Li X, Yang X, Han C

Open source

DOI
10.1159/000491667
Published
2018
Container
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1159/000491667,
  title = {CD24 is a Potential Biomarker for Prognosis in Human Breast Carcinoma.},
  author = {Jing X and Cui X and Liang H and Hao C and Yang Z and Li X and Yang X and Han C},
  year = {2018},
  journal = {Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology},
  doi = {10.1159/000491667},
  url = {https://doi.org/10.1159/000491667}
}

RIS

TY  - JOUR
TI  - CD24 is a Potential Biomarker for Prognosis in Human Breast Carcinoma.
AU  - Jing X
AU  - Cui X
AU  - Liang H
AU  - Hao C
AU  - Yang Z
AU  - Li X
AU  - Yang X
AU  - Han C
PY  - 2018
JO  - Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
DO  - 10.1159/000491667
UR  - https://doi.org/10.1159/000491667
ER  - 

APA

X, J., X, C., H, L., C, H., Z, Y., X, L., X, Y., & C, H. (2018). CD24 is a Potential Biomarker for Prognosis in Human Breast Carcinoma.. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology. https://doi.org/10.1159/000491667

Source records